Benzinga··Vandana SinghTevogen Bio Pursues Apozeal Acquisition to Strengthen Generics Portfolio
Tevogen Bio ($TVGN) pursues Apozeal acquisition to bolster generics platform; stock plunges 15.41% despite initial rally, trading at 52-week lows amid strategic uncertainty.
TVGNTVGNWacquisitionreverse stock split